On Friday, Shares of National Oilwell Varco, Inc. (NYSE:NOV), dropped -2.78% to $54.20.
National Oilwell Varco, declared that Jeremy D. Thigpen has informed the Company of his resignation as Senior Vice President and Chief Financial Officer, in order to become Chief Executive Officer of Transocean, one of NOV’s largest customers. Scott K. Duff, NOV’s Vice President and Chief Accounting Officer has been named as Interim Chief Financial Officer, effective right away.
Mr. Thigpen has been serving as the Company’s Chief Financial Officer since 2012, and is resigning to become Chief Executive Officer of Transocean. Mr. Thigpen has served as the Company’s President – Downhole Pumping and Solutions from 2007 to 2012. Preceding to that, Mr. Thigpen was the President of the Company’s Downhole Tools group from 2003 until 2007. Mr. Thigpen has been with National Oilwell Varco for 18 years, holding various positions during his career.
National Oilwell Varco will conduct a search to identify a new Chief Financial Officer. In the interim period, Scott Duff will continue as Chief Accounting Officer and has stepped in to serve as Chief Financial Officer until the search is accomplished. Mr. Duff holds a BBA in Accounting from the University of Texas at San Antonio and is a Certified Public Accountant. He held accounting positions at KPMG, Ernst & Young, and SBC before joining National-Oilwell in 2004. Mr. Duff has served as National Oilwell Varco’s Vice President and Chief Accounting Officer since 2014 and had formerly served as the Company’s Vice President of Internal Audit since 2005.
National Oilwell Varco, Inc. designs, manufactures, and sells equipment and components used in oil and gas drilling, completion, and production; and provides oilfield services to the upstream oil and gas industry worldwide.
Shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), declined -2.73% to $11.41, during its last trading session.
Keryx Biopharmaceuticals, declared the appointment of John F. Neylan, MD to the newly created position of Chief Medical Officer. In this role, Dr. Neylan will be responsible for oversight of medical affairs, clinical development and pharmacovigilence at Keryx.
Preceding to joining industry, Dr. Neylan held prestigious positions in academia, counting Professor of Medicine at Emory University and Assistant Professor of Medicine at UC Davis, serving at both institutions as Medical Director of the respective Renal Transplant Programs, with oversight of the clinical research programs. Dr. Neylan received his BS from Duke University and his MD from Rush Medical School in Chicago. He accomplished his Internal Medicine residency at Vanderbilt University and fellowships in Nephrology and in Transplantation and Immunogenetics at Brigham and Women’s Hospital, Harvard University. Dr. Neylan has a proven track record for successful INDs, NDA/BLAs, and MAAs involving NCEs, polymers, biologics and RNA-based therapeutics and has authored more than 70 scientific manuscripts and book chapters. He is Past-President of the American Society of Transplantation and past Board Member of the National Kidney Foundation, and a past Industry Representative on the FDA Cardiovascular and Renal Drugs Advisory Committee.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia.
At the end of Friday’s trade, Shares of Hancock Holding Company (NASDAQ:HBHC), dwindled -2.72% to $28.93.
Hancock Holding Company, declared its financial results for the first quarter of 2015. Operating income for the first quarter of 2015 was $44.7 million, or $.55 per diluted common share, contrast to $46.4 million, or $.56, in the fourth quarter of 2014. Operating income was $49.1 million, or $.58, in the first quarter of 2014. We define our operating income as net income not taking into account tax-effected securities transactions gains or losses and nonoperating expense items. Nonoperating expenses totaled $7.3 million and $9.7 million (pre-tax), in the first quarter of 2015 and fourth quarter of 2014, respectively. There were no adjustments between operating income and net income for the first quarter 2014. Administration believes that operating income is one useful measure of our financial performance that assists investors compare the company’s fundamental operational performance from period to period. The financial tables comprise a reconciliation of net income to operating income.
Net income for the first quarter of 2015 was $40.2 million, or $.49 per diluted common share, contrast to $40.1 million, or $.48 and $49.1 million, or $.58, in the fourth and first quarters of 2014 respectively.
Hancock Holding Company operates as the bank holding company for Whitney Bank that provides a range of community banking services to commercial, small business, and retail customers. The company offers various deposit products, counting noninterest-bearing demand deposits, interest-bearing transaction accounts, savings accounts, money market deposit accounts, and time deposit accounts.
Finally, PMC-Sierra Inc. (NASDAQ:PMCS), ended its last trade with -2.71% loss, and closed at $8.99.
PMC-Sierra, presented at the China SDN/NFV Conference 2015, held at the JW Marriott Hotel Beijing Central, in Beijing, China, April 22 – 23, 2015.
On Wednesday, April 22, Tao Lang, senior product marketing manager for PMC’s Communications Business Unit, presented “Software Defined Platforms Accelerates SDN Adoption in Enterprise Access.”
He talked about how Chinese carriers are looking to evolve enterprise access networks to packet in a similar fashion to mobile backhaul. Utilizing a programmable architecture, software defined access platforms will solve networking challenges facing both carriers and OEMs.
PMC-Sierra, Inc. designs, develops, markets, and supports semiconductor solutions for communications network infrastructure equipment worldwide. Its semiconductor devices enable networking equipment primarily in three markets, counting storage, optical, and mobile networks.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
